The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphoma

BACKGROUND: Mantle cell lymphoma (MCL) is an incurable B cell-derived malignant tumor with a median overall survival of 4–5 years. Mer tyrosine kinase (MerTK) has been reported to be aberrantly expressed in leukemia, melanoma, and gastric cancer, and plays a pivotal role in the process of oncogenesi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Hematol Oncol
Main Authors: Shi, Cunzhen, Li, Xiangqun, Wang, Xiaogan, Ding, Ning, Ping, Lingyan, Shi, Yunfei, Mi, Lan, Lai, Yumei, Song, Yuqin, Zhu, Jun
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2018
Fag:
Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5859520/
https://ncbi.nlm.nih.gov/pubmed/29554921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-018-0584-6
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker